ArticleOncotarget2017

Comparison of treatment outcome between living donor liver transplantation and sorafenib for patients with hepatocellular carcinoma beyond the Milan criteria.

Yuri Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.